Associations among Body Composition, Androgen Levels, and Human Immunodeficiency Virus Status in Adolescents

Journal of Adolescent Health

Volumn 39, Issue 2, 2006, Pages 164-173

  Moscicki, Anna Barbara ^a   Ellenberg, Jonas H ^b   Murphy, Debra A ^c   Jiahong, Xu ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WESTAT   (United States)

Author keywords

Adolescents; Androgen levels; Body composition; Human immunodeficiency virus

Indexed keywords

ANDROGEN; ANTIRETROVIRUS AGENT; FAT; TESTOSTERONE;

ADOLESCENT; ANDROGEN BLOOD LEVEL; ANTHROPOMETRY; APPETITE; ARTICLE; BICEPS BRACHII MUSCLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALCULATION; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; FEMALE; HEALTH CARE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEAN BODY WEIGHT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRIORITY JOURNAL; SKINFOLD THICKNESS; TRICEPS BRACHII MUSCLE; VIRUS LOAD;

ADOLESCENT; BODY COMPOSITION; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; TESTOSTERONE;

EID: 33745948184     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2005.11.020     Document Type: Article

References (38)

1. Palenicek J.P., Graham N.M.H., He Y.D., et al. Weight loss prior to clinical AIDS as predictor of survival. J Acquir Immune Defic Syndr Hum Retrovirol 10 (1995) 366-373
2. Guenter P., Muurahaninen N., Simons G., et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr 6 (1993) 1130-1138
3. Wheeler D.A., Gibert C.L., Launer C.A., et al. Weight loss as a predictor of survival and disease progression in HIV infection; Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 18 (1998) 80-85
4. Tang A.M., Forrester J., Spiegelman D., et al. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31 (2002) 230-236
5. Grinspoon S., Corcoran C., Miller K., et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 82 (1997) 1332-1337
6. Mulligan K., Tai V.W., and Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 15 (1998) 43-48
7. Kotler D.P., Thea D.M., Heo M., et al. Relative influences of sex, race, environment, and HIV infection on body composition in adults. Am J Clin Nutr 69 (1999) 432-439
8. Paton N., Macallan D., Jebb S., et al. Longitudinal changes in body composition measured with a variety of methods in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 14 (1997) 119-127
9. Forrester J.E., Spiegelman D., Tchetgen E., et al. Weight loss and body-composition changes in men and women infected with HIV. Am J Clin Nutr 76 (2002) 1428-1434
10. Christeff N., Lortholary O., Casassus P., et al. Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected men. Exp Clin Endocrinol Diabetes 104 (1996) 130-136
11. Engelson E.S., Rabkin J.G., Rabkin R., and Kotler D.P. Effects of testosterone upon body composition. J Acquir Immune Defic Syndr Hum Retrovirol 11 (1996) 510-511
12. Coodley G.O., Loveless M.O., Nelson H.D., and Coodley M.K. Endocrine function in the HIV wasting syndrome. J Acquir Immune Defic Syndr 7 (1994) 46-51
13. Laudat A., Blum L., Guechot J., et al. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men. relationship with the CD4 cell counts. Eur J Endocrinol 133 (1995) 418-424
14. Dworkin M.S., and Williamson J.M. AIDS wasting syndrome. trends, influence on opportunistic infections, and survival. J Acquir Immune Defic Syndr 33 (2003) 267-273
15. Smit E., Skolasky R.L., Dobs A.S., et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol 156 (2002) 211-218
16. Wanke C.A., Silva M., Knox T.A., et al. Weight loss and wasting remain common complications in individuals infected with human immumodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 31 (2000) 803-805
17. Jaquet D., Levine M., Ortega-Rodriguez E., et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 14 (2000) 2123-2128
18. Gertner J.M., Kaufman F.R., Donfield S.M., et al. Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys. hemophilia growth and development study. J Pediatr 124 (1994) 896-902
19. Lepage P., Van de Perre P., Van Vliet G., et al. Clinical and endocrinologic manifestations in perinatally human immunodeficiency virus type I-infected children aged 5 years or older. Am J Dis Child 145 (1991) 1248-1251
20. Wilson C.M., Houser J., Partlow C., et al. The REACH (Reaching for Excellence in Adolescent Care and Health) project. study design, methods, and population profile. J Adolesc Health 29 (2001) 8-18
21. Frisancho A.R. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 34 (1981) 2540-2545
22. Harrison H.R., Costin M., Meder J.B., et al. Cervical Chlamydia trachomatis infection in university women. relationship to history, contraception, ectopy and cervicitis. Am J Obstet Gynecol 153 (1985) 244-251
23. National Center for Health Statistics (NCHS). Third National Health and Nutrition Examination Survey, (NHANES III). National Center for Health Statistics (NCHS). Available from: http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm#NHANESIII.
24. Chumlea W.C., Roche A.F., and Thissen D. The FELS method of assessing the skeletal maturity of the hand-wrist. Am J Hum Biol 2 (1989) 175-183
25. van Belle G. Statistical Rules of Thumb (2002), John Wiley, New York, NY
26. SAS Institute Inc. SAS/STAT User's Guide, Version 8, Vol 2-3 (1999), SAS Institute Inc, Cary, NC
27. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
28. Kotler D.P., Rosenbaum K., Wang J., and Pierson R.N. Studies of body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retroviol 20 (1999) 228-237
29. Mulligan K., Anastos K., Justman J., et al. Fat distribution in HIV-infected women in the United States. DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 38 (2005) 18-22
30. Miller K., Corcoran C., Armstrong C., et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting. a pilot study. J Clin Endocrinol Metab 83 (1998) 2717-2725
31. Elbers J.M., Asscheman H., Seidell J.C., et al. Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab 82 (1997) 2044-2047
32. Korhonen S., Hippelainen M., Vanhala M., et al. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women. a controlled community-based study. Fertil Steril 79 (2003) 1327-1334
33. Ibanez L., Ong K., de Zegher F., et al. Fat distribution in non-obese girls with and without precocious pubarche. central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol (Oxf) 58 (2003) 372-379
34. Kirschner M.A., Samojlik E., Drejka M., et al. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 70 (1990) 473-479
35. Dolaneczky M., and Liblane M. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. J Adolesc Health 23 (1998) 81-88
36. Sattler F.R., Jaque S.V., Schroeder E.T., et al. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 84 (1999) 1268-1276
37. Hengge U.R., Stocks K., Wiehler H., et al. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting. AIDS 17 (2003) 699-710
38. Brambilla P., Bricalli D., Sala N., et al. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS 15 (2001) 2415-2422